Results 21 to 30 of about 9,874 (219)

Systematic Evaluation of the Distribution of Immune Cells following Subcutaneous Administration of Haemophilus Influenzae Type B Vaccine to Mice

Diseases, 2023
The Haemophilus influenzae type B (Hib) conjugate vaccine is the most effective way to prevent Hib infection in infants and young children, and it is designed to induce the production of antibodies against polyribosylribitol phosphate (PRP) to protect ...
Yao He, Yuxiu Zhao, Hongyang Liang, Xue Wang, Haoyue Lan, Dongyang Tian, Yan Li, Hui Wang   +7 more
doaj   +1 more source

Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.

PLoS ONE, 2018
BackgroundAcellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence.
Ayman Chit, Hossein Zivaripiran, Thomas Shin, Jason K H Lee, Antigona Tomovici, Denis Macina, David R Johnson, Michael D Decker, Jianhong Wu   +8 more
doaj   +1 more source

Safety and Immunogenicity of a Fully Liquid Vaccine Containing Five-Component Pertussis-Diphtheria-Tetanus-Inactivated Poliomyelitis-Haemophilus influenzae Type B Conjugate Vaccines Administered at Two, Four, Six and 18 Months of Age

Canadian Journal of Infectious Diseases and Medical Microbiology, 2007
OBJECTIVE: The safety, immunogenicity and lot consistency of a fully liquid, five-component acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b (DTaP ...
Ronald Gold, Luis Barreto, Santiago Ferro, John Thippawong, Roland Guasparini, William Meekison, Margaret Russell, Elaine Mills, Dana Harrison, Pierre Lavigne   +9 more
doaj   +1 more source

Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review

Vaccines, 2019
The growing number of available vaccines that can be potentially co-administered makes the assessment of the safety of vaccine co-administration increasingly relevant but complex.
Jorgen Bauwens, Luis-Henri Saenz, Annina Reusser, Nino Künzli, Jan Bonhoeffer   +4 more
doaj   +1 more source

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups

Emerging Microbes and Infections, 2022
Pertussis incidence has increased in many countries and the disease occurs among all age groups, suggesting the need for booster immunizations through life. In addition to determining the concentration of anti-pertussis toxin (PT) antibodies, the ability
Aapo Knuutila, Pauline Versteegen, Alex-Mikael Barkoff, Pieter van Gageldonk, Jussi Mertsola, Guy Berbers, Qiushui He   +6 more
doaj   +1 more source

Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.

PLoS ONE, 2021
IntroductionThe burden of IgE-mediated food allergy in Australian born children is reported to be among the highest globally. This illness shares risk factors and frequently coexists with asthma, one of the most common noncommunicable diseases of ...
Gladymar Pérez Chacón, Parveen Fathima, Mark Jones, Rosanne Barnes, Peter C Richmond, Heather F Gidding, Hannah C Moore, Thomas L Snelling   +7 more
doaj   +2 more sources

Lichen planus following tetanus–diphtheria–acellular pertussis vaccination: A case report and review of the literature

SAGE Open Medical Case Reports, 2018
Lichen planus is an inflammatory dermatosis with a prevalence of approximately 1%. Recent meta-analyses show that patients with hepatitis C virus have a 2.5- to 4.5-fold increased risk of developing lichen planus.
Heather C Rosengard, Chikoti M Wheat, Matthew P Tilson, Jonathan D Cuda   +3 more
doaj   +1 more source

Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine.

, 1994
The safety and immunogenicity of an acellular pertussis vaccine containing the genetically detoxified pertussis toxin PT-9K/129G, filamentous hemagglutinin, and pertactin, together with diphtheria and tetanus toxoids, were compared with those of a whole ...
RAPPUOLI R. AND THE ITALIAN MULTICENTER GROUP FOR THE STUDY OF RECOMBINANT ACELLULAR PERTUSSIS VACCINE, PEPPOLONI, Samuele, MAIDA A., FURLAN R., UXA F., CARAPELLA DE LUCA E., NENCIONI L., CONTU B., TITONE L., MOIRAGHI A., STRAMARE D., DI PISA F., PODDA A.   +12 more
core   +2 more sources

Efficacy of Acellular Pertussis Vaccine

Journal of the Japanese Association for Infectious Diseases, 1990
An outbreak of pertussis occurred in one room of a residential facility where 19 children aged 5 to 36 months were residing. They were prospectively surveyed to estimate the efficacy of acellular pertussis vaccine. Among the 19 residents, 9 were immunized with acellular pertussis vaccine.
SAITO, Tsuyoshi, AKAMATSU, Takayuki, AOYAMA, Tatsuo, IWAI, Hidehito, GONDA, Takaaki, MURASE, Yuji, YAMASHITA, Naoya, IWATA, Takashi   +7 more
openaire   +3 more sources

Haemophilus influenzae type b reemergence after combination immunization

, 2006
An increase in Haemophilus influenzae type b (Hib) in British children has been linked to the widespread use of a diphtheria/tetanus/acellular pertussis combination vaccine (DTaP-Hib).
Mary P.E. Slack, Heath, PT, Diane Irving, Slack, MPE, Nik G. Johnson, Lee, YC ; https://orcid.org/, Irving, D, Sheldon, J, Gail F. Balfour, Joanna Sheldon, Johnson, NG, Ruggeberg, JU, Balfour, GF, Slack, MP, Y. Chen Lee, Heath, PI, Pollard, AJ, Jens U. Ruggeberg, Paul T. Heath, Pollard, Andrew, Andrew J. Pollard, Lee, YC, Liddy, H, Helen Liddy   +23 more
core   +1 more source